research
past
decad
revolution
use
therapeut
valuabl
protein
varieti
clinic
treatment
gene
express
mani
differ
system
essenti
determin
system
offer
advantag
product
recombin
protein
ideal
express
system
would
one
produc
safe
biolog
activ
materi
lowest
cost
use
modifi
mammalian
cell
recombin
dna
techniqu
advantag
result
product
ident
natur
origin
howev
cultur
cell
expens
carri
limit
scale
use
microorgan
bacteria
permit
manufactur
larger
scale
introduc
disadvantag
produc
product
differ
appreci
product
natur
origin
exampl
protein
usual
glycosyl
human
glycosyl
bacteria
furthermor
human
protein
express
high
level
e
coli
frequent
acquir
unnatur
conform
accompani
intracellular
precipit
owe
lack
proper
fold
disulfid
bridg
product
recombin
protein
plant
mani
potenti
advantag
gener
biopharmaceut
relev
clinic
medicin
first
plant
system
econom
industri
facil
use
ferment
bioreactor
system
second
technolog
alreadi
avail
harvest
process
plant
plant
product
larg
scale
third
purif
requir
elimin
plant
tissu
contain
recombin
protein
use
food
edibl
vaccin
fourth
plant
direct
target
protein
intracellular
compart
stabl
even
express
directli
certain
compart
chloroplast
fifth
amount
recombin
product
produc
approach
industrialscal
level
last
health
risk
aris
contamin
potenti
human
pathogen
toxin
minim
decad
sinc
express
assembl
immunoglobulin
ig
heavi
light
chain
function
antibodi
first
shown
transgen
tobacco
plant
proven
versatil
product
system
mani
form
antibodi
includ
fullsiz
igg
iga
chimer
igg
iga
secretori
igg
iga
singlechain
fv
fragment
scfv
fab
fragment
heavychain
variabl
domain
recent
list
extend
includ
bispecif
antibodi
made
genet
fusion
two
differ
scfv
via
flexibl
peptid
linker
plant
great
potenti
virtual
unlimit
sourc
inexpens
monoclon
antibodi
dub
plantibodi
human
anim
therapeut
tabl
yet
consensu
best
plant
speci
tissu
commerci
antibodi
product
antibodi
express
date
tobacco
although
recent
potato
soybean
alfalfa
rice
wheat
also
use
success
major
advantag
use
green
tissu
tobacco
alfalfa
soybean
sheer
product
alfalfa
tobacco
support
sever
crop
cut
per
year
potenti
annual
biomass
yield
tonn
ha
tonn
ha
respect
contrast
maximum
yield
wheat
rice
corn
seed
tonn
ha
tonn
ha
tonn
ha
respect
advantag
tobacco
includ
rel
eas
genet
manipul
product
larg
number
seed
million
per
plant
impend
need
explor
altern
use
hazard
crop
howev
seed
like
fewer
phenol
compound
less
complex
mixtur
protein
lipid
green
leav
might
advantag
purif
anoth
advantag
seed
tuber
abil
store
long
period
level
scfv
rice
seed
show
signific
declin
storag
room
temperatur
six
month
potato
tuber
cold
storag
month
lost
function
antibodi
short
period
time
five
seven
day
dri
tobacco
alfalfa
leav
also
store
littl
loss
scfv
ref
igg
antibodi
purif
antibodi
store
plant
materi
advantag
process
facil
need
near
field
use
continu
year
rather
larg
batch
date
four
antibodi
made
plant
potenti
use
human
therapeut
one
test
human
chimer
secretori
iggiga
antibodi
surfac
antigen
streptococcu
mutan
primari
causal
agent
tooth
decay
tobaccoproduc
antibodi
appli
topic
teeth
found
effect
igg
produc
murin
hybridoma
prevent
recolon
mutan
second
antibodi
human
antiherpessimplex
viru
hsv
antibodi
made
soybean
effect
prevent
vagin
transmiss
mous
model
activ
indistinguish
vitro
vivo
monoclon
antibodi
produc
cell
cultur
third
antibodi
carcinoembryon
antigen
cea
recent
express
rice
wheat
cea
cellsurfac
glycoprotein
one
bestcharacter
tumorassoci
antigen
antibodi
cea
use
vivo
tumor
imag
well
antibodybas
cancer
therapi
level
scfv
seed
show
signific
declin
storag
room
temperatur
six
month
antibodi
express
rice
cell
cultur
fourth
antibodi
exampl
novel
use
plantproduc
antibodi
altern
product
system
plant
viru
vector
use
produc
tumorspecif
vaccin
transient
tobacco
treatment
lymphoma
antibodi
gene
express
scfv
deriv
mous
bcell
lymphoma
plantproduc
scfv
use
immun
mice
gener
antiidiotyp
antibodi
antibodi
bind
portion
antibodi
mice
protect
infect
lymphoma
produc
origin
antibodi
group
use
modifi
plant
viral
vector
produc
therapeut
use
antibodi
plant
includ
antibodi
colorectalcancerassoci
antigen
ref
although
vector
might
find
limit
use
rapid
product
antibodi
necessari
perhap
greenhous
product
accept
regulatori
agenc
eg
us
food
drug
administr
dept
agricultur
environment
protect
agenc
test
plantibodi
yet
commerci
product
therefor
estim
cost
difficult
find
involv
mani
assumpt
cost
produc
igg
alfalfa
grown
greenhous
estim
us
g
compar
us
g
hybridomaproduc
antibodi
planet
biotechnolog
mountain
view
ca
usa
compar
cost
per
gram
purifi
iga
made
cell
cultur
transgen
goat
grain
tonn
ha
green
biomass
tonn
ha
fig
express
level
signific
impact
cost
best
express
level
report
g
leaf
secretori
iga
ref
final
cost
well
us
g
significantli
undercut
cost
cell
cultur
us
g
transgen
anim
product
system
us
g
biggest
compon
cost
plantibodi
purif
howev
express
seed
rice
wheat
open
possibl
oral
administr
therapeut
antibodi
without
need
expens
purif
properti
ig
depend
glycosyl
eg
bind
monocyt
fc
receptor
one
conserv
nglycosyl
site
ch
domain
igg
structur
nlink
glycan
plantand
murineproduc
guy
determin
compar
plantibodi
nglycan
structur
divers
highmannos
type
plantibodi
oligosaccharid
xylos
fucos
link
man
glcnac
core
linkag
typic
plant
found
mammalian
nglycan
plantibodi
also
lack
sialic
acid
repres
sugar
content
mous
monoclon
antibodi
differ
glycan
structur
appear
effect
antigen
bind
affin
vitro
might
signific
vivo
either
igg
produc
alfalfa
serum
halflif
balbc
mice
indistinguish
hybridomaproduc
antibodi
howev
concern
potenti
immunogen
allergen
plantibodi
use
human
therapeut
mucos
applic
like
present
problem
peopl
plant
glycoprotein
ubiquit
human
diet
evid
allerg
reaction
human
antimous
antibodi
hama
respons
patient
receiv
topic
oral
applic
secretori
iga
specif
mutan
protein
microbi
viral
pathogen
earliest
exampl
chosen
show
feasibl
transgen
plant
express
system
rational
key
immunogen
protein
major
pathogen
could
synthes
plant
tissu
fed
edibl
cost
plant
compar
green
biomass
tonn
ha
seed
product
tonn
ha
cost
differ
base
primarili
product
cost
assum
purif
cost
loss
purif
system
subunit
vaccin
human
commerci
import
anim
proof
concept
sinc
shown
use
sever
bacteri
viral
protein
tabl
practic
aspect
choos
particular
foodstuff
deliv
defin
dose
vaccin
explor
effort
way
establish
clear
regulatori
path
develop
edibl
vaccin
oral
deliveri
vaccin
attract
altern
inject
larg
reason
low
cost
easi
administr
chanc
acquir
mucos
immun
infecti
agent
enter
bodi
across
mucos
surfac
also
increas
oral
vaccin
howev
major
concern
oral
vaccin
degrad
protein
compon
stomach
gut
elicit
immun
respons
guard
degrad
sever
deliveri
vehicl
develop
ferri
intact
protein
gut
includ
recombin
strain
attenu
microorgan
bioencapsul
vehicl
liposom
transgen
plant
tissu
earli
work
plantbas
subunit
vaccin
use
readili
transform
speci
tobacco
potato
tomato
howev
attract
speci
express
subunit
vaccin
compon
high
level
solubl
protein
stabl
storag
seed
crop
cereal
particularli
suitabl
embryo
fraction
rich
solubl
protein
easili
separ
seed
tissu
increas
concentr
antigen
thu
decreas
dose
size
choic
crop
defin
type
materi
fed
mani
plant
tissu
consum
raw
other
must
process
process
facilit
creation
homogen
sampl
enabl
defin
dose
size
import
heat
pressur
treatment
involv
destroy
antigen
altern
process
step
appli
candid
vaccin
compon
enterotoxigen
strain
e
coli
consist
b
subunit
heatlabil
toxin
ltb
express
corn
typic
mg
dose
ltb
could
deliv
embryo
fraction
decreas
volum
dose
cook
whole
corn
snack
increas
palat
enhanc
stabl
storag
fig
case
neither
treatment
degrad
antigen
commerci
anim
vaccin
relev
protein
express
plant
tissu
constitut
major
proport
diet
heat
pressur
treatment
necessari
key
exampl
illustr
rang
candid
protein
investig
plant
express
system
use
given
tabl
plantexpress
antigen
shown
abl
induc
mucos
serum
immun
respons
administ
parenter
oral
experiment
anim
test
case
offer
protect
subsequ
pathogen
challeng
challeng
model
vaccin
candid
success
test
clinic
trial
appropri
commerci
nativ
anim
trial
thu
edibl
vaccin
deliv
plant
tissu
process
plant
product
show
great
potenti
efficaci
target
organ
bioencapsul
ltb
transgen
corn
materi
result
increas
mucos
immun
respons
compar
achiev
nake
antigen
fed
mice
presum
antigen
protect
degrad
gut
augur
well
develop
plantbas
edibl
vaccin
quantiti
plant
tissu
constitut
vaccin
dose
must
practic
size
consumpt
thu
achiev
high
level
express
crucial
express
vaccin
compon
plant
increas
use
rang
leader
polyadenyl
signal
optim
codon
usag
plant
express
could
also
rais
cross
transform
line
variou
genet
background
approach
success
appli
boost
protein
product
corn
also
import
vaccin
compon
present
nativ
form
transgen
plant
tissu
assess
sever
case
examin
size
synthes
protein
abil
form
higherord
complex
mirror
microbi
viral
structur
relev
show
enzymat
receptorbind
activ
stabil
heterolog
protein
assembl
multisubunit
structur
depend
cellular
environ
therefor
subcellular
locat
favor
locat
express
select
subunit
vaccin
compon
cell
surfac
endoplasm
reticulum
golgi
bodi
antibodi
transient
express
system
candid
vaccin
sequenc
incorpor
plant
viral
surfac
protein
also
investig
extens
high
level
express
achiev
relat
strategi
edibl
vaccin
use
transgen
plant
express
autoantigen
wherebi
larg
oral
dose
autoantigen
inhibit
develop
autoimmun
diseas
mechan
oral
toler
approach
success
mous
model
diabet
gener
level
pharmaceut
protein
produc
transgen
plant
less
total
solubl
protein
need
commerci
feasibl
protein
must
purifi
plantderiv
recombin
hepatitisb
surfac
antigen
induc
low
level
serum
antibodi
respons
small
human
studi
probabl
reflect
low
level
express
ng
g
fresh
weight
transgen
lettuc
spite
recent
improv
express
level
potato
view
clinic
trial
express
level
increas
practic
purpos
also
even
though
norwalk
viru
capsid
protein
express
potato
caus
oral
immun
consum
food
express
level
low
largescal
oral
administr
total
solubl
protein
express
gene
encod
human
protein
transgen
plant
disappointingli
low
human
serum
albumin
total
solubl
protein
human
protein
c
total
solubl
protein
erythropoietin
total
solubl
protein
human
fresh
weight
tabl
synthet
gene
code
human
epiderm
growth
factor
express
total
solubl
protein
transgen
tobacco
spite
sever
success
report
highlevel
express
nonhuman
protein
eg
phytas
glucanas
via
nuclear
genom
great
need
increas
express
level
human
blood
protein
enabl
commerci
product
pharmacolog
import
protein
plant
one
altern
approach
express
foreign
protein
chloroplast
higher
plant
foreign
gene
integr
tobacco
chloroplast
genom
give
copi
per
cell
result
accumul
recombin
protein
total
solubl
protein
chloroplast
transform
use
two
flank
sequenc
homolog
recombin
insert
foreign
dna
spacer
region
function
gene
chloroplast
genom
thu
target
foreign
gene
precis
locat
elimin
posit
effect
upon
express
frequent
observ
transgen
plant
gene
insert
nuclear
genom
addit
gene
silenc
observ
chloroplast
transform
wherea
common
phenomenon
nuclear
transform
chloroplast
genet
engin
environment
friendli
approach
minim
sever
environment
concern
importantli
chloroplast
process
eukaryot
protein
includ
enabl
correct
fold
format
disulfid
bridg
chaperonin
protein
present
chloroplast
might
function
fold
assembl
nonn
protein
prokaryot
eukaryot
origin
also
chloroplast
protein
activ
disulfid
bond
oxidationreduct
cycl
use
plastid
thioredoxin
system
protein
disulfid
isomeras
accumul
larg
quantiti
fulli
assembl
form
human
somatotropin
correct
disulfid
bond
total
solubl
protein
provid
strong
evid
hyperexpress
assembl
pharmaceut
protein
use
approach
fold
assembl
foreign
protein
elimin
need
expens
vitro
process
pharmaceut
protein
produc
recombin
organ
exampl
total
oper
cost
commerci
product
human
insulin
e
coli
associ
vitro
process
format
disufid
bridg
cleavag
methionin
purif
like
repres
cost
biopharmaceut
product
plant
commerci
product
insulin
e
coli
chromatographi
account
oper
expens
equip
cost
therefor
new
approach
necessari
minim
elimin
chromatographi
product
pharmaceut
protein
one
success
recent
approach
target
pharmaceut
protein
seed
oil
bodi
shown
hirudin
anticoagul
first
isol
leech
hirudo
medicinali
oleosinhirudin
fusion
protein
target
oil
bodi
brassica
napu
seed
purifi
flotat
centrifug
commerci
product
canada
anoth
novel
approach
use
gvgvp
fusion
protein
facilit
singlestep
purif
without
use
chromatographi
gvgvp
proteinbas
polym
encod
synthet
gene
low
temperatur
exist
extend
molecul
upon
rais
temperatur
transit
rang
polym
hydrophob
fold
dynam
structur
call
aggreg
hydrophob
associ
form
twist
filament
use
approach
singlestep
purif
insulinpolym
fusion
recent
shown
invers
temperatur
transit
offer
sever
advantag
includ
facilit
scaleup
purif
gram
kilogram
carmonasanchez
h
daniel
unpublish
yet
anoth
recent
approach
use
chaperonin
protein
fold
foreign
protein
cuboid
crystal
allow
purif
singl
step
centrifug
one
addit
advantag
method
protect
foreign
protein
cellular
proteas
plantderiv
biopharmaceut
meet
standard
safeti
perform
product
system
howev
mani
herbal
medicin
exempt
close
scrutini
requir
meet
standard
classif
nutrit
supplement
sever
environment
concern
rais
interest
group
confus
public
percept
paramount
import
regul
agenc
distinguish
real
perceiv
public
concern
scientif
versu
nonscientif
biopharmaceut
potenti
harm
capabl
persist
environ
might
accumul
nontarget
organ
precautionari
measur
taken
induct
biopharmaceut
product
harvest
done
case
glucocerebrosidas
might
one
approach
minim
environment
exposur
provid
use
viral
vector
introduc
addit
environment
regulatori
concern
express
potenti
harm
protein
form
must
treat
activ
might
minim
risk
exposur
exampl
hirudin
produc
fusion
protein
inact
form
activ
purifi
seed
anoth
hotli
debat
environment
concern
outcross
transgen
pollen
weed
relat
crop
express
harm
pharmaceut
protein
nontarget
plant
result
outcross
might
creat
public
concern
neg
percept
sever
gene
contain
method
current
investig
includ
apomixi
incompat
genom
transgen
mitig
control
seed
dormanc
shatter
suicid
gene
infertil
barrier
male
steril
matern
inherit
engin
foreign
gene
via
chloroplast
genom
shown
contain
transgen
effect
although
except
chloroplast
genom
show
biparent
inherit
eg
pine
exampl
altern
strategi
rnase
gene
express
control
tissuespecif
promot
destroy
tapetum
select
anther
develop
result
male
steril
plant
also
concern
express
harm
protein
transgen
pollen
exampl
controversi
observ
toxic
effect
bacillu
thuringiensi
bt
corn
pollen
milkwe
asclepia
spp
fed
monarch
butterfli
larva
signific
impact
public
percept
even
though
valid
studi
repeatedli
question
engin
biopharmaceut
via
chloroplast
genom
might
solut
although
cri
protein
bt
express
high
level
leav
total
solubl
protein
toxic
observ
milkwe
dust
transgen
pollen
fed
monarch
butterfli
larva
howev
date
chloroplast
genet
engin
shown
tobacco
potato
recent
sever
academ
industri
laboratori
initi
project
extend
technolog
use
crop
also
report
product
glycoprotein
transgen
chloroplast
anoth
public
concern
presenc
antibiot
resist
gene
product
use
select
marker
edibl
part
genet
modifi
crop
howev
sever
approach
avail
gener
plant
transgen
nuclear
chloroplast
genom
without
use
antibiot
select
practic
consider
dictat
choic
biopharmaceut
protein
crop
produc
includ
yield
storag
condit
contain
properti
initi
set
run
cost
purif
strategi
size
market
environment
concern
public
percept
compet
technolog
access
sever
altern
approach
optim
protein
synthesi
plant
environment
sound
manner
augur
well
safe
product
biopharmaceut
transgen
plant
greater
avail
protein
popul
requir
